54 135 (Mycophenolate mofetil 500 mg)

Pill imprint 54 135 has been identified as Mycophenolate mofetil 500 mg.

Mycophenolate mofetil is used in the treatment of nephrotic syndrome; organ transplant, rejection prophylaxis; dermatomyositis; multiple sclerosis; autoimmune hepatitis (and more), and belongs to the drug class selective immunosuppressants. There is positive evidence of human fetal risk during pregnancy. Mycophenolate mofetil 500 mg is not subject to the Controlled Substances Act.

See also related documents.

Imprint Search

Images for 54 135

Mycophenolate mofetil 500 mg 54 135
Mycophenolate mofetil 500 mg 54 135
Mycophenolate mofetil
Imprint:
54 135
Strength:
500 mg
Color:
White
Size:
1.00 mm
Shape:
Elliptical / Oval
Availability:
Prescription only
Drug Class:
Selective immunosuppressants
Pregnancy Category:
D - Positive evidence of risk
CSA Schedule:
N - Not a controlled drug
Manufacturer:
Roxane Laboratories, Inc.
National Drug Code (NDC):
00054-0166
Inactive Ingredients:
croscarmellose sodium
hypromelloses
magnesium stearate
microcrystalline cellulose
polydextrose
corn starch
titanium dioxide
triacetin
polyethylene glycol
povidone

View Details Print Page

Disclaimer: Every effort has been made to ensure that the information provided is accurate, up-to-date, and complete, but no guarantee is made to that effect. If you have questions about the drugs you are taking, check with your doctor, nurse or pharmacist.

Copyright 2014 Drugs.com, National Library of Medicine, Truven Health Analytics and Cerner Multum, Inc. All Rights Reserved.

Hide
(web1)